4//SEC Filing
Chan Gerald 4
Accession 0001127602-25-000400
CIK 0001492422other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:12 PM ET
Size
6.6 KB
Accession
0001127602-25-000400
Insider Transaction Report
Form 4
Chan Gerald
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-01+11,199→ 11,199 totalExercise: $31.91Exp: 2032-12-31→ Common Stock (11,199 underlying) - Award
Common Stock
2025-01-01+6,267→ 17,705 total
Footnotes (1)
- [F1]This option was granted on January 1, 2025. The option vests quarterly on the last day of each quarter from the date of grant, subject to his continued service as a director and expires seven years after the date of grant.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001636579
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:12 PM ET
- Size
- 6.6 KB